Evidence map›Paper›PMID 25397881›Full record

ArticlePloS one2014

Intronic variants in the NFKB1 gene may influence hearing forecast in patients with unilateral sensorineural hearing loss in Meniere's disease.

Sonia Cabrera, Elena Sanchez, Teresa Requena, Manuel Martinez-Bueno, Jesus Benitez, Nicolas Perez, Gabriel Trinidad, Andrés Soto-Varela, Sofía Santos-Perez, Eduardo Martin-Sanz and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. The Impact of Genetic Factors in Ménière's Disease.International journal of molecular sciences · 2026
    Review
  6. Article
  7. Redox Modulation of Meniere Disease byCurrent neuropharmacology · 2024
    Article
  8. Article
  9. Article
  10. Cytokines and Inflammation in Meniere Disease.Clinical and experimental otorhinolaryngology · 2022
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 2 countries.

Sonia CabreraOtology & Neurotology Group CTS495, Department of Genomic Medicine- Centro de Genómica e Investigación Oncológica - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO), Granada, Spain.
Elena SanchezDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York City, New York, United States of America.
Teresa RequenaOtology & Neurotology Group CTS495, Department of Genomic Medicine- Centro de Genómica e Investigación Oncológica - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO), Granada, Spain.
Manuel Martinez-BuenoGroup of Genetics of Complex Diseases, Department of Genomic Medicine - Centro de Genómica e Investigación Oncológica - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO), Granada, Spain.
Jesus BenitezDepartment of Otolaryngology, Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas, Spain.
Nicolas PerezDepartment of Otolaryngology, Clinica Universidad de Navarra, Pamplona, Spain.
Gabriel TrinidadDivision of Otoneurology, Department of Otorhinolaryngology, Complejo Hospitalario Badajoz, Badajoz, Spain.
Andrés Soto-VarelaDivision of Otoneurology, Department of Otorhinolaryngology, Complexo Hospitalario Universitario, Santiago de Compostela, Spain.
Sofía Santos-PerezDivision of Otoneurology, Department of Otorhinolaryngology, Complexo Hospitalario Universitario, Santiago de Compostela, Spain.
Eduardo Martin-SanzDepartment of Otolaryngology, Hospital Universitario de Getafe, Getafe, Spain.
Jesus FraileDepartment of Otolaryngology, Hospital Miguel Servet, Zaragoza, Spain.
Paz PerezDepartment of Otorhinolaryngology, Hospital Cabueñes, Gijón, Spain.
Marta E Alarcon-RiquelmeGroup of Genetics of Complex Diseases, Department of Genomic Medicine - Centro de Genómica e Investigación Oncológica - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO), Granada, Spain.
Angel BatuecasDepartment of Otolaryngology, Hospital Universitario Salamanca, Salamanca, Spain.
Juan M Espinosa-SanchezOtology & Neurotology Group CTS495, Department of Genomic Medicine- Centro de Genómica e Investigación Oncológica - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO), Granada, Spain; Department of Otorhinolaryngology, Hospital San Agustin, Linares, Jaen, Spain.
Ismael AranDepartment of Otolaryngology, Complexo Hospitalario de Pontevedra, Pontevedra, Spain.
Jose A Lopez-EscamezOtology & Neurotology Group CTS495, Department of Genomic Medicine- Centro de Genómica e Investigación Oncológica - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO), Granada, Spain; Department of Otolaryngology, Hospital de Poniente, El Ejido, Almería, Spain.
Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research · ESComplejo Hospitalario Universitario de Santiago · ESCentro de Implantología Cirugía Oral y Maxilofacial · ESClinica Universidad de Navarra · ESComplejo Hospitalario de Pontevedra · ESComplejo Hospitalario de Salamanca · ESHospital Universitario De Cabueñes · ESHospital Universitario de Getafe · ESHospital Universitario de Gran Canaria Doctor Negrín · ESHospital Universitario Miguel Servet · ESIcahn School of Medicine at Mount Sinai · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meniere's disease is an episodic vestibular syndrome associated with sensorineural hearing loss (SNHL) and tinnitus. Patients with MD have an elevated prevalence of several autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis and psoriasis), which suggests a shared autoimmune background. Functional variants of several genes involved in the NF-κB pathway, such as REL, TNFAIP3, NFKB1 and TNIP1, have been associated with two or more immune-mediated diseases and allelic variations in the TLR10 gene may influence bilateral affectation and clinical course in MD. We have genotyped 716 cases of MD and 1628 controls by using the ImmunoChip, a high-density genotyping array containing 186 autoimmune loci, to explore the association of immune system related-loci with sporadic MD. Although no single nucleotide polymorphism (SNP) reached a genome-wide significant association (p<10(-8)), we selected allelic variants in the NF-kB pathway for further analyses to evaluate the impact of these SNPs in the clinical outcome of MD in our cohort. None of the selected SNPs increased susceptibility for MD in patients with uni or bilateral SNHL. However, two potential regulatory variants in the NFKB1 gene (rs3774937 and rs4648011) were associated with a faster hearing loss progression in patients with unilateral SNHL. So, individuals with unilateral MD carrying the C allele in rs3774937 or G allele in rs4648011 had a shorter mean time to reach hearing stage 3 (>40 dB HL) (log-rank test, corrected p values were p = 0.009 for rs3774937 and p = 0.003 for rs4648011, respectively). No variants influenced hearing in bilateral MD. Our data support that the allelic variants rs3774937 and rs4648011 can modify hearing outcome in patients with MD and unilateral SNHL.

Indexed as

AllelesDisease ProgressionFemaleGenetic Predisposition to DiseaseHaplotypesHearingHearing Loss, SensorineuralHumansIntronsKaplan-Meier EstimateLinkage DisequilibriumMaleMeniere DiseaseMiddle AgedNF-kappa B p50 SubunitPolymorphism, Single NucleotideNF-kappa B p50 SubunitNFKB1 protein, human

Identifiers

PMID25397881
PMCPMC4232390
OpenAlexW2158272793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.